American Society of Clinical Oncology

SHERPA: White

People

  1. Hudis
    Hudis
  2. Norton
    Norton
  3. Robson
    Robson
  4. Offit
    Offit
  5. Seidman
    Seidman
  6. Goldfrank
    Goldfrank
  7. Panageas
    Panageas
  8. Brogi
    Brogi
  9. D'Andrea-Carlino
    D'Andrea-Carlino
  10. Fornier
    Fornier

Groups

  1. Breast Medicine Service (23)
  2. Department of Medicine (23)
  3. Solid Tumor Oncology Division (23)
  4. Survivorship Research (16)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (11)
  6. Population Sciences Research Program (9)
  7. GSK Faculty (8)
  8. Surgery (6)
  9. Clinical Genetics Service (5)
  10. Epidemiology and Biostatistics (4)
Search Within
  1. "Breast Medicine Service"
  2. "2005"
Formats
  1. Meeting Abstract (17)
  2. Journal Article (6)
Groups
  1. Breast Medicine Service (23)
  2. Department of Medicine (23)
  3. Solid Tumor Oncology Division (23)
  4. Survivorship Research (16)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (11)
  6. Population Sciences Research Program (9)

More Groups

People
  1. Clifford Hudis (11)
  2. Larry Norton (11)
  3. Mark Robson (7)
  4. Kenneth Offit (5)
  5. Andrew Seidman (4)
  6. Deborah Goldfrank (3)

More People

Years
  1. 2005 (23)
Publications
  1. Journal of Clinical Oncology (23)

Results (23)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Quality of life with malignant bowel obstruction: Provider assessed health state utilities
    Meeting Abstract

    Wong, S. L.; Wong, D.; Elkin, E. B.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • A feasibility study of an aromatase inhibitor (Al), letrozole (L) and the antibody to vascular endothelial growth factor (VEGF), bevacizurnab (B), in patients (pts) with hormone receptor-positive metastatic breast cancer (MBC)
    Meeting Abstract

    Traina, T. A.; Dickler, M. N.; Caravelli, J. F.; Yeh, B. M.; Brogi, E.; Panageas, K.; Flores, S. A.; Norton, L.; Hudis, C.; Rugo, H.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Phase 1 pharmacokinetic and pharmacodynamic trial of docetaxel and 17AAG (17-allylamino-17-demethoxygeldanamycin)
    Meeting Abstract

    Solit, D. B.; Egorin, M.; Kopil, C.; Delacruz, A.; Shaffer, D.; Slovin, S.; Morris, M.; Kelly, W. K.; Rosen, N.; Scher, H.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Serum peptide profiling (SPP) by mass spectrometry (MS) to identify postmenopausal women with metastatic breast cancer
    Meeting Abstract

    Smith, K. L.; Villanueva, J.; D'Andrea, G.; Moynahan, M. E.; Sklarin, N.; Norton, L.; Hudis, C.; Tempst, P.; Robson, M.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Serum HER2 extracellular domain (ECD) levels and efficacy of weekly (W) or every 3-weekly (q3W) paclitaxel (P) with or without trastuzumab (T) in patients (pts) with metastatic breast cancer (MBC): CALGB 150002/9840
    Meeting Abstract

    Seidman, A. D.; Broadwater, G.; Carney, W.; Dressler, L.; Berry, D.; Norton, L.; Hudis, C.; Winer, E.; Ellis, M.; Harris, L.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Change in circulating endothelial cells (CEC) and tumor cells (CTC) in patients (pts) receiving bevacizumab and erlotinib for metastatic breast cancer (MBC) predicts stable disease at first evaluation
    Meeting Abstract

    Rugo, H. S.; Dickler, M. N.; Scott, J. H.; Moore, D. H.; Melisko, M.; Yeh, B. M.; Caravelli, J.; Brogi, E.; Hudis, C.; Park, J. W.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • A phase I clinical and pharmacokinetic study of weekly docetaxel followed by flavopiridol: Promising activity in metastatic pancreatic cancer
    Meeting Abstract

    Rathkopf, D.; Fornier, M.; Shah, M. A.; Kortmansky, J.; O'reilly, E.; Winkelmann, J.; Balzano, L.; Kelsen, D. P.; Schwartz, G. K.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Impact of HER2 status in breast cancer patients receiving stereotactic radiosurgery for brain metastases
    Meeting Abstract

    O'meara, W. P.; Seidman, A. D.; Yamada, Y.; McCormick, B.; Diamond, S.; Gutin, P. H.; Narayana, A.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Prevalence of BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish (AJ) families with breast cancer (BC) and pancreatic cancer (PC)
    Meeting Abstract

    Marcotrigiano, M. C.; Wadsworth, E.; Balistreri, L.; Schluger, A.; Offit, K.; Robson, M.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • BRCA haploinsufficiency inhuman breast tumorigenesis
    Meeting Abstract

    King, T. A.; Li, W.; Yee, C.; Gemignani, M. L.; Olvera, N.; Brogi, E.; Robson, M. E.; Offit, K.; Norton, L.; Borgen, P. I.; more...
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save